4.7 Review

Mitochondrial degradation of amyloidogenic proteins - A new perspective for neurodegenerative diseases

Journal

PROGRESS IN NEUROBIOLOGY
Volume 181, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pneurobio.2019.101660

Keywords

Mitochondrial degradation; Neurodegeneration; Parkinson's disease; Alpha-synuclein; Alzheimer's disease; Amyloid beta; SOD1; Huntingtin; PreP; HtrA2; Omi

Categories

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [LA 3609/2-1]
  2. Wellcome Trust
  3. UK Medical Research Council (MRC)
  4. Alzheimer Research UK (ARUK)
  5. Infinitus China Ltd.
  6. MRC [MR/K02292X/1, G0902243] Funding Source: UKRI

Ask authors/readers for more resources

This perspective article outlines mechanisms of mitochondrial import and protein degradation and how these have been linked to alpha-synuclein and Amyloid beta (A beta) homeostasis. Our aim is to underpin and stimulate the debate on the recent conception of mitochondria as protein degrading organelles, which suggests that mitochondria are more directly involved in neurodegenerative diseases than previously assumed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available